Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 3/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | GRK2 | P25098 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | APAF1 | O14727 | 1/20 | 0.45 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.45 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19677620 | 0.94 | BBOX1 (0.57) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| SCHEMBL15661967 | 0.92 | BBOX1 (0.55) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| Sulfuric Acid SCHEMBL2103287 | 0.82 | POLB (0.49) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| Taurine SCHEMBL16346517 | 0.82 | BLM (0.44) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| SCHEMBL25663649 | 0.81 | BBOX1 (0.73) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| SCHEMBL26789436 | 0.81 | BBOX1 (0.73) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| SCHEMBL352054 | 0.81 | DNM1 (0.48) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| SCHEMBL34469744 | 0.80 | BBOX1 (0.60) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| Sulfuric Acid SCHEMBL2913751 | 0.80 | POLB (0.47) | BBOX1DNM1POLBGRK2L3MBTL1 | |
| SCHEMBL989047 | 0.80 | POLB (0.47) | BBOX1DNM1POLBGRK2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569595-B2 | Bioprosthetic tissue preparation | EDWARDS LIFESCIENCES CORPORATION (US) | 2026-03-10 | — | — | US | claimed |
| US-12338397-B2 | Materials for separating mixtures via selective absorption | UNIVERSITY OF KANSAS (US) | 2025-06-24 | — | — | US | claimed |
| US-20250197817-A1 | VIRUS PURIFICATION METHOD | THE UNIVERSITY OF TOKYO (JP) | 2025-06-19 | — | — | US | claimed |
| CN-119824421-A | Molybdenum etching solution | 湖北兴福电子材料股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-20240115595-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | TEAM MEDICAL, LLC (US) | 2024-04-11 | — | — | US | claimed |
| WO-2024055011-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | TEAM MEDICAL, LLC (US) | 2024-03-14 | — | — | WO | claimed |
| US-20240000999-A1 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | UNIV CALIFORNIA (US) | 2024-01-04 | — | — | US | claimed |
| WO-2023182428-A1 | VIRUS PURIFICATION METHOD | 国立大学法人 東京大学 | 2023-09-28 | — | — | WO | claimed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | claimed |
| WO-2023044455-A2 | RNA STABILIZATION | TEAM MEDICAL LLC (US) | 2023-03-23 | — | — | WO | claimed |
| US-20220331749-A1 | MATERIALS FOR SEPARATING MIXTURES VIA SELECTIVE ABSORPTION | UNIVERSITY OF KANSAS | 2022-10-20 | — | — | US | claimed |
| CN-114258310-A | Bioprosthetic tissue preparation | 爱德华兹生命科学公司 | 2022-03-29 | — | — | CN | claimed |
| EP-3965841-A1 | BIOPROSTHETIC TISSUE PREPARATION | Edwards Lifesciences Corporation (US) | 2022-03-16 | — | — | EP | claimed |
| WO-2019078655-A1 | COMPOSITION FOR INFILTRATING BIOMOLECULE INTO TISSUE INCLUDING SULFOBETAINE-BASED ZWITTERIONIC SURFACTANT, AND USE THEREOF | 재단법인대구경북과학기술원 | 2019-04-25 | — | — | WO | claimed |
| EP-4725960-A2 | SWEET PROTEIN FROM TRUFFLE | Mycotechnology, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4361621-B1 | SAMPLE ANALYSIS METHOD, CAPILLARY ELECTROPHORESIS SOLUTION, AND SAMPLE ANALYSIS KIT | ARKRAY INC (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092310-A1 | CAS12A COMPOSITIONS AND METHODS | NEW ENGLAND BIOLABS, INC. (US) | 2026-04-02 | — | — | US | disclosed |
| EP-2992056-A1 | NOVEL POLYSILOXANE-BASED FOULING-RELEASE COATS | Hempel A/S (DK) | 2016-03-09 | — | — | EP | disclosed |
| US-20150306223-A1 | METHODS AND COMPOSITIONS FOR INACTIVATING ENVELOPED VIRUSES | BIOGEN IDEC MA INC. (US) | 2015-10-29 | — | — | US | disclosed |
| WO-2014177159-A1 | NOVEL POLYSILOXANE-BASED FOULING-RELEASE COATS | HEMPEL A/S (DK) | 2014-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092310-A1 | CAS12A COMPOSITIONS AND METHODS | RNASEL, RBM12, NT5C2 | BBOX1 1958/4885DNM1 1494/4885POLB 112/4885 |
| US-12569595-B2 | Bioprosthetic tissue preparation | BCHE, LNPEP, DPEP1 | BBOX1 716/4885DNM1 2605/4885POLB 1526/4885 |
| US-20240115595-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | RBM22, HNRNPUL2, HNRNPUL1 | BBOX1 3754/4885DNM1 3814/4885POLB 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.